✦ LIBER ✦

Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma

✍ Scribed by Michelagnoli, M P; Lewis, I J; Gattamaneni, H R; Bailey, C C; Lashford, L S

Book ID: 110001049
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 85 KB
Volume: 79
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6690187

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of primary mediastinal large B

Treatment of primary mediastinal large B cell lymphoma with an alternating chemotherapy regimen based on high-dose methotrexate

✍ T. Fietz; W. U. Knauf; M. Hänel; A. Franke; M. Freund; E. Thiel; for the East Ge 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 177 KB

Feasibility of an accelerated multi-cycl

Feasibility of an accelerated multi-cycle high-dose chemotherapy regimen including high-dose thiotepa for patients (Pts) with poor risk ovarian cancer (OC)

✍ J. Crown; K.M. Chan; M. O'Leary; J. Ballot; T. King; J. Murphy; P. Lenehan; J. D 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 168 KB

High dose chemotherapy with ifosfamide,

High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults

✍ Jean-Pierre Droz; Pierre Biron; Jean-Pierre Lotz 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 2 views

Pilot study of tandem high-dose chemothe

Pilot study of tandem high-dose chemotherapy and autologous stem cell transplantation with a novel combination of regimens in patients with poor risk lymphoma

✍ Papadopoulos, K P; Noguera-Irizarry, W; Wiebe, L; Hesdorffer, C S; Garvin, J; Ni 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

A combination chemotherapy with low dose

A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage: A pilot study

✍ Shin-ichiro Kuriya; Kazunori Murai; Yasuro Miyairi; Taiju Utsugisawa; Yasushi Na 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

## BACKGROUND. Even now, no definitely effective therapy is inducted to high risk myelodysplastic syndromes (MDS) and their leukemic stage (MDS-AML) except bone marrow transplantation. ## METHODS. Ten patients with high risk MDS and 6 with MDS-AML were treated with daily low doses of cytarabine

A comparison of early intensive methotre

A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial

✍ Lauer, S J; Shuster, J J; Mahoney, D H; Winick, N; Toledano, S; Munoz, L; Kiefer 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB